CAS 1619931-27-9
:Formel:C27H27N5O3
InChl:InChI=1S/C27H27N5O3/c1-17-10-21(14-28-13-17)27(33)31-22-7-5-6-19(11-22)18(2)30-26-16-29-15-23(32-26)20-8-9-24(34-3)25(12-20)35-4/h5-16,18H,1-4H3,(H,30,32)(H,31,33)/t18-/m0/s1
InChI Key:JHJNPOSPVGRIAN-SFHVURJKSA-N
SMILES:CC1=CC(=CN=C1)C(=O)NC2=CC=CC(=C2)[C@H](C)NC3=NC(=CN=C3)C4=CC(=C(C=C4)OC)OC
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
7 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
(S)-N-(3-(1-((6-(3,4-Dimethoxyphenyl)Pyrazin-2-Yl)Amino)Ethyl)Phenyl)-5-Methylnicotinamide
CAS:(S)-N-(3-(1-((6-(3,4-Dimethoxyphenyl)Pyrazin-2-Yl)Amino)Ethyl)Phenyl)-5-MethylnicotinamideFormel:C27H27N5O3Reinheit:99%Molekulargewicht:469.54Seralutinib
CAS:(S)-N-(3-(1-((6-(3,4-Dimethoxyphenyl)pyrazin-2-yl)amino)ethyl)phenyl)-5-methylnicotinamideFormel:C27H27N5O3Reinheit:99%Molekulargewicht:469.54Seralutinib
CAS:Seralutinib (GB002) is an inhibitor of inhaled PDGFRα and PDGFRβ. It is used in the study for pulmonary arterial hypertension.Formel:C27H27N5O3Reinheit:99.09%Farbe und Form:SolidMolekulargewicht:469.535(S)-N-(3-(1-((6-(3,4-Dimethoxyphenyl)pyrazin-2-yl)amino)ethyl)phenyl)-5-methylnicotinamide
CAS:Reinheit:98%Molekulargewicht:469.545Seralutinib
CAS:Seralutinib is a small molecule inhibitor of the receptor tyrosine kinase (RTK) family. Seralutinib binds to RTKs and inhibits their activation by binding to the ATP-binding site. It specifically binds to the epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor 2 (VEGFR2), and c-Kit, which are RTKs that have been implicated in cancer progression.Formel:C27H27N5O3Reinheit:Min. 95%Molekulargewicht:469.5 g/mol(S)-N-(3-(1-((6-(3,4-Dimethoxyphenyl)pyrazin-2-yl)amino)ethyl)phenyl)-5-methylnicotinamide
CAS:Formel:C27H27N5O3Reinheit:98%Farbe und Form:SolidMolekulargewicht:469.5350Ref: IN-DA01KBIH
Ausgelaufenes produkt
